Finally, activation of YAP by XMU-MP-1 upregulated β-catenin and EAAT2 expression, which partially alleviated neurodegeneration and motor deficits in ALS mice (Figure 9). This evidence concerns the gene SLC1A2 and amyotrophic lateral sclerosis.